Paul M. Armistead, Ph.D.
Affiliations: | 2000 | University of North Carolina, Chapel Hill, Chapel Hill, NC |
Area:
Biological Application of Transition Metal Redox ChemistryGoogle:
"Paul Armistead"Mean distance: 8.34 | S | N | B | C | P |
Parents
Sign in to add mentor| H. Holden Thorp | grad student | 2000 | UNC Chapel Hill | |
| (The catalytic oxidation of guanine adsorbed to indium tin oxide electrodes.) | ||||
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Zhu J, Patel T, Miller JA, et al. (2020) Influence of Germline Genetics on Tacrolimus Pharmacokinetics and Pharmacodynamics in Allogeneic Hematopoietic Stem Cell Transplant Patients. International Journal of Molecular Sciences. 21 |
| Story C, Kuxhausen M, Spellman SR, et al. (2020) HLA Genotyping Does Not Predict Outcomes in Hematopoietic Cell Transplantation (alloHCT) Biology of Blood and Marrow Transplantation. 26: 73-74 |
| Foster MC, Fedoriw Y, Pulley W, et al. (2019) Detection of Measurable Residual Disease (MRD) in Peripheral Blood: First Report of a Novel Microfluidic Platform in Patients with Acute Myeloid Leukemia (AML) Blood. 134: 1417-1417 |
| Muller R, Toughiri R, Bartakova A, et al. (2019) Abstract 4214: A microfluidic platform to capture and detect cancer cells in Leukemia patients Cancer Research. 79: 4214-4214 |
| Kasow KA, Brondon JE, Armistead PM, et al. (2019) Utilizing Data to Modify Standard Operating Procedures and Improve Outcomes: Evaluating Complications after Donor Lymphocyte Infusions in Allogeneic Stem Cell Transplant Recipients Biology of Blood and Marrow Transplantation. 25: S128-S129 |
| Lansford JL, Dharmasiri U, Chai S, et al. (2018) Computational modeling and confirmation of leukemia-associated minor histocompatibility antigens. Blood Advances. 2: 2052-2062 |
| Bruce DW, Stefanski HE, Vincent BG, et al. (2017) Type 2 innate lymphoid cells treat and prevent acute gastrointestinal graft-versus-host disease. The Journal of Clinical Investigation |
| Story CM, Lansford JL, Moore DT, et al. (2017) Class I HLA Peptide Epitope Binding Efficiency Has No Impact on Graft Vs. Host Disease Incidence Following Allogeneic Hematopoietic Cell Transplantation Blood. 130: 1987-1987 |
| Armistead PM, Friend R, Xenakis J, et al. (2017) Increased Immune Suppression is Associated with Worse Overall Survival in Allogeneic Hematopoietic Cell Transplant Patients Receiving Reduced Intensity Continuous Infusion Busulfan Biology of Blood and Marrow Transplantation. 23: S261-S262 |
| Attayek PJ, Hunsucker SA, Sims CE, et al. (2016) Identification and isolation of antigen-specific cytotoxic T lymphocytes with an automated microraft sorting system. Integrative Biology : Quantitative Biosciences From Nano to Macro |